These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6521073)

  • 1. Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.
    Yamada K; Kubo K; Shuto K; Nakamizo N
    Jpn J Pharmacol; 1984 Nov; 36(3):283-90. PubMed ID: 6521073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxation of carbocyclic thromboxane A2-induced contractions of isolated coronary arteries by nifedipine.
    Towart R; Perzborn E
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):249-51. PubMed ID: 7063050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of vasoconstrictor actions of endothelin-1 in cerebral, coronary, and mesenteric arteries of the dog.
    Tanoi C; Suzuki Y; Shibuya M; Sugita K; Masuzawa-Ito K; Asano M
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):568-79. PubMed ID: 1380600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonist.
    Yamada K; Shuto K; Kubo K; Nakamizo N
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):141-54. PubMed ID: 6329114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin on vasoconstriction induced by thromboxane A2 in porcine coronary artery.
    Yanagisawa-Miwa A; Ito H; Sugimoto T
    Circulation; 1990 May; 81(5):1654-9. PubMed ID: 2184947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thromboxane on contraction of canine mesenteric and lingual arteries.
    Greenberg SS; Wang Y; Xie J; Smartz L; Rammazatto L; Curro FA
    J Dent Res; 1991 Sep; 70(9):1278-85. PubMed ID: 1918577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S; Ho WK; Ishida U
    J Pharmacol Exp Ther; 1980 Nov; 215(2):357-62. PubMed ID: 7441499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of vasoconstriction induced by 9,11-epithio-11,12-methano-thromboxane A2 in the rabbit coronary artery.
    Kanmura Y; Itoh T; Kuriyama H
    Circ Res; 1987 Mar; 60(3):402-9. PubMed ID: 3581448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tripeptide ZAMI-420 inhibits thromboxane-induced gastric vasoconstriction and ischaemia.
    Moroni D; Gervasi GB; Patella P; Visentin L; Maselli MA; Bergamaschi M
    Int J Tissue React; 1983; 5(3):249-52. PubMed ID: 6654624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picotamide inhibits a wide spectrum of agonist-induced smooth muscle contractions in porcine renal interlobar and coronary arteries.
    Li B; Huang R; Wang R; Liu Y; Stief CG; Hennenberg M
    Pharmacol Res Perspect; 2021 May; 9(3):e00771. PubMed ID: 33929093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of carbocyclic thromboxane A2 and its interaction with prostaglandin I2 and verapamil in isolated arteries.
    Toda N
    Circ Res; 1982 Dec; 51(6):675-82. PubMed ID: 6754126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries.
    Arshad M; Vijay V; Floyd BC; Marks B; Sarabu MR; Wolin MS; Gupte SA
    Ann Thorac Surg; 2006 Jun; 81(6):2147-54. PubMed ID: 16731144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries.
    Asano M; Aoki K; Suzuki Y; Matsuda T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in the response to vasoconstrictor agents of dog and monkey isolated coronary arteries.
    Miwa K; Toda N
    Br J Pharmacol; 1984 May; 82(1):295-301. PubMed ID: 6587928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory action of niflumic acid on noradrenaline- and 5-hydroxytryptamine-induced pressor responses in the isolated mesenteric vascular bed of the rat.
    Criddle DN; de Moura RS; Greenwood IA; Large WA
    Br J Pharmacol; 1997 Mar; 120(5):813-8. PubMed ID: 9138686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of thromboxane A2 analogs and prostaglandins in isolated dog arteries.
    Toda N; Nakajima M; Okamura T; Miyazaki M
    J Cardiovasc Pharmacol; 1986; 8(4):818-25. PubMed ID: 2427824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
    Awano K; Yokoyama M; Fukuzaki H
    J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modification of platelet-induced coronary vasoconstriction by a thromboxane receptor antagonist.
    Verheggen R; Schrör K
    J Cardiovasc Pharmacol; 1986; 8(3):483-90. PubMed ID: 2425162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries.
    Bolla M; You D; Loufrani L; Levy BI; Levy-Toledano S; Habib A; Henrion D
    Hypertension; 2004 Jun; 43(6):1264-9. PubMed ID: 15096470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.